Hall Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $349K | Buy |
4,308
+182
| +4% | +$17.4K | 0.12% | 84 |
|
|
2025
Q4 | $396K | Sell |
4,126
-187
| -4% | -$18.2K | 0.15% | 68 |
|
|
2025
Q3 | $411K | Buy |
4,313
+117
| +3% | +$10.8K | 0.16% | 70 |
|
|
2025
Q2 | $366K | Buy |
4,196
+3
| +0.1% | +$254 | 0.15% | 72 |
|
|
2025
Q1 | $377K | Sell |
4,193
-25
| -0.6% | -$2.24K | 0.17% | 67 |
|
|
2024
Q4 | $337K | Buy |
+4,218
| New | +$365K | 0.16% | 77 |
|
|
2024
Q2 | $312K | Sell |
3,960
-337
| -8% | -$27.6K | 0.15% | 80 |
|
|
2024
Q1 | $374K | Buy |
4,297
+36
| +0.8% | +$3.07K | 0.18% | 72 |
|
|
2023
Q4 | $351K | Sell |
4,261
-95
| -2% | -$7.24K | 0.21% | 67 |
|
|
2023
Q3 | $341K | Buy |
4,356
+130
| +3% | +$10.9K | 0.22% | 69 |
|
|
2023
Q2 | $372K | Buy |
4,226
+120
| +3% | +$10.3K | 0.21% | 75 |
|
|
2023
Q1 | $331K | Sell |
4,106
-310
| -7% | -$25.3K | 0.2% | 80 |
|
|
2022
Q4 | $343K | Sell |
4,416
-385
| -8% | -$31.2K | 0.21% | 76 |
|
|
2022
Q3 | $388K | Sell |
4,801
-834
| -15% | -$75K | 0.26% | 72 |
|
|
2022
Q2 | $506K | Sell |
5,635
-1,650
| -23% | -$167K | 0.33% | 61 |
|
|
2022
Q1 | $808K | Buy |
7,285
+90
| +1% | +$9.51K | 0.47% | 49 |
|
|
2021
Q4 | $744K | Buy |
7,195
+1,289
| +22% | +$149K | 0.42% | 51 |
|
|
2021
Q3 | $740K | Buy |
5,906
+130
| +2% | +$16.8K | 0.47% | 51 |
|
|
2021
Q2 | $717K | Buy |
+5,776
| New | +$725K | 0.46% | 51 |
|
|
2020
Q4 | $674K | Buy |
5,750
+167
| +3% | +$18.4K | 0.49% | 48 |
|
|
2020
Q3 | $580K | Buy |
5,583
+725
| +15% | +$72.8K | 0.46% | 49 |
|
|
2020
Q2 | $445K | Buy |
4,858
+245
| +5% | +$23.5K | 0.37% | 56 |
|
|
2020
Q1 | $416K | Buy |
4,613
+128
| +3% | +$13.6K | 0.43% | 53 |
|
|
2019
Q4 | $509K | Buy |
4,485
+160
| +4% | +$17.6K | 0.41% | 55 |
|
|
2019
Q3 | $470K | Buy |
4,325
+70
| +2% | +$7.3K | 0.41% | 55 |
|
|
2019
Q2 | $414K | Sell |
4,255
-100
| -2% | -$9.13K | 0.35% | 60 |
|
|
2019
Q1 | $397K | Sell |
4,355
-40
| -0.9% | -$3.58K | 0.35% | 62 |
|
|
2018
Q4 | $400K | Buy |
4,395
+175
| +4% | +$16.4K | 0.4% | 60 |
|
|
2018
Q3 | $415K | Buy |
4,220
+425
| +11% | +$39.3K | 0.36% | 64 |
|
|
2018
Q2 | $325K | Sell |
3,795
-25
| -0.7% | -$2.09K | 0.31% | 70 |
|
|
2018
Q1 | $306K | Sell |
3,820
-75
| -2% | -$6.19K | 0.29% | 72 |
|
|
2017
Q4 | $315K | Buy |
3,895
+207
| +6% | +$16.6K | 0.28% | 75 |
|
|
2017
Q3 | $287K | Buy |
3,688
+243
| +7% | +$20.2K | 0.26% | 74 |
|
|
2017
Q2 | $306K | Buy |
+3,445
| New | +$290K | 0.29% | 74 |
|
Other funds holding MDT
VCM
VPM
Hall Capital Management's MDT Position: Q1 2026 in Review
Hall Capital Management increased its Medtronic (MDT) stake by 4.4% in Q1 2026, buying an estimated $17.4K and bringing the position to 4,308 shares worth $349K. The position accounts for 0.12% of the portfolio, ranked #84.
Hall Capital Management first reported a position in MDT in Q2 2017 and has held it in 34 quarters since. The position peaked at $808K in Q1 2022. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Hall Capital Management held 4,308 shares of Medtronic worth $349K as of Q1 2026.
- Hall Capital Management bought 182 Medtronic shares in Q1 2026, an estimated $17.4K.
- Medtronic made up 0.12% of Hall Capital Management's portfolio in Q1 2026, its #84 holding.
- Hall Capital Management first reported a position in Medtronic in Q2 2017 and has held it in 34 quarters since.
- Hall Capital Management's Medtronic position peaked at $808K in Q1 2022.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Hall Capital Management's 13F filing for Q1 2026, filed 11 May 2026.